Africa CDC says countries without variant found in SA should use AstraZeneca vaccine

African countries that have not reported the circulation of the 501Y.V2 coronavirus variant first identified in SA should proceed with the rollout of the AstraZeneca Covid-19 vaccine, the AU's disease control body said.

Anban Pillay, deputy director-general at the Department of health said the country would look to recover money spent on the vaccine doses but was still finalising how to do that.
Anban Pillay, deputy director-general at the Department of health said the country would look to recover money spent on the vaccine doses but was still finalising how to do that. (REUTERS/Benoit Tessier/File Photo)

African countries that have not reported the circulation of the 501Y.V2 coronavirus variant first identified in SA should proceed with the rollout of the AstraZeneca Covid-19 vaccine, the African Union's disease control body said on Thursday.

For countries that have reported circulation of the 501Y.V2 variant, they should accelerate their preparedness to introduce all vaccines that have received emergency use authorisation, Africa CDC Director John Nkengasong told a news conference.

"Consideration should be given to the effectiveness of the vaccine against the 501Y.V2variant," Nkengasong said.


Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Comment icon